GRAZAX

This brand name is authorized in Austria, Estonia, Spain, Finland, France, Croatia, Ireland, Lithuania, Netherlands, Poland, Romania, Turkey

Active ingredients

The drug GRAZAX contains one active pharmaceutical ingredient (API):

1 Grass pollen extract (Phleum pratense) UNII 65M88RW2EG - PHLEUM PRATENSE POLLEN

Read about Grass pollen

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V01AA02	Grass pollen	V Various → V01 Allergens → V01A Allergens → V01AA Allergen extracts
Discover more medicines within V01AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1233885, 1233908, 1298684
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 68398
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 025425, 025736
Country: FR	Base de données publique des médicaments	Identifier(s): 64210260
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-377814790
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1093013, 1093014, 1093015
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 205621
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100174027
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68401001, W68401002, W68401003
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8681078093013, 8681078093020